Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

North Estonia Medical Centre · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-myeloma
multiple myeloma, transplant eligible, talquetamab, teclistamab, mrd negativity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861612
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.